Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-22-000277
Filing Date
2022-01-04
Accepted
2022-01-04 17:02:09
Documents
1
Period of Report
2021-12-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 12373
  Complete submission text file 0001567619-22-000277.txt   13731
Mailing Address C/O METABOLIX, INC. 21 ERIE STREET CAMBRIDGE MA 02139
Business Address
Strobeck Matthew (Reporting) CIK: 0001377832 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39659 | Film No.: 22507151

Mailing Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301
Business Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301 303-417-0500
BIODESIX INC (Issuer) CIK: 0001439725 (see all company filings)

EIN.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories